Articles

Technology designed to effectively address blood clots by combining capabilities of larger devices with smaller catheters. 

Expanse Ice Receives FDA 510(k) Clearance for ICE Aspiration System for Peripheral Arterial, Venous Systems

The rationale behind transforming case management in healthcare.

From Toggling Tediously Between Systems to Achieving Whole-Person Care

The latest news for pharma industry insiders.

Pharma Pulse 4/22/24: Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Climate Change Increases Rate of Infectious Diseases & more

Videos

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, suggests how to improve visibility and risk management for cold chain shipping. 

LogiPharma Europe 2024: Niklas Adamsson Discusses Ways to Improve Visibility and Risk Management for Cold Chain Shipping

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, offers his thoughts on how changing customer needs are affecting cold chain logistics. 

LogiPharma Europe 2024: Envirotainer COO Discusses Reshaping Cold Chain Logistics and Adapting to Disruptions

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio. 

FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease 

Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

LogiPharma Europe 2024: Properly Applying Diversity, Equity, and Inclusion Initiatives Within the Life Sciences Supply Chain 

Data displayed rapid and sustained B-cell depletion, with 97.2% of study patients with relapsing and primary progressive multiple sclerosis experiencing no relapses. 

Genentech Shares Promising Results from Phase III OCARINA II Study of Ocrevus for Elapsing, Primary Progressive Multiple Sclerosis

Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.

News